Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
July 1, 2008

Wellcome Trust Program Selects Illumina Technology to Analyze 90K DNA Samples

  • Researchers participating in a new initiative funded by the Wellcome Trust have chosen Illumina’s Infinium HD BeadChips to analyze 90,000 DNA samples. The goal is to decipher the molecular basis of human disease and includes participation from research groups around the globe.

    Scientists at the Wellcome Trust Case Control Consortium 2 (WTCCC2) and 12 independent consortia will collect DNA samples and analyze them for both SNPs and copy number variants. In addition to 90,000 samples collected from study participants, 6,000 control samples will be collected and analyzed using Illumina's Infinium HD Human1M-Duo BeadChip.